Olivia Putri

Olivia Putri

Auto-generated profile, based on publicly available information

Olivia Putri

Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Biomedicine, School of Life Sciences, Indonesia International Institute for Life Sciences (i3L), Jakarta, Indonesia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2024 in The Lancet Microbe
Verified
Journal Article
Open access
YKYusuke Kosugi
Yusuke Kosugi
APArnon Plianchaisuk
Arnon Plianchaisuk
OPOlivia Putri
Olivia Putri
KUKeiya Uriu
Keiya Uriu
YKYu Kaku
Yu Kaku
KSKei Sato
Kei Sato

24 March 2023 in Indonesian Journal of Life Sciences
Verified
Journal Article
Open access
PDF file
OPOlivia Putri
Olivia Putri
MSMegan Angelita Salim
Megan Angelita Salim
AGAileen Gunawan
Aileen Gunawan
DDDevin Devin
Devin Devin
EAEzrela Amaris
Ezrela Amaris
GFGabriella Gita Febriana
Gabriella Gita Febriana
Tuberculosis (TB) caused by the pathogenic bacteria Mycobacterium tuberculosis (MTb) still remains a highly prevalent disease, particularly in low and middle-income countries. Due to the bacteria’s atypical cell wall structure, ability to form granuloma, and capacity to switch between replicating and non-replicating states in the host lung parenchyma, the fundamental treatment of patients diagnosed with TB involves a 6-month long daily drug administration. With Indonesia ranking among the nations with the highest TB burden worldwide, there has been an alarming increase of drug-resistant MTb (DR-MTb) strains all over the country in recent years. However, there are currently limited studies available that highlight MTb resistance profiles across different regions within Indonesia. The major risk factors contributing to the emergence and spread of TB in Indonesia include health conditions, environmental conditions, and socioeconomic status. Furthermore, natural compounds and drug repurposing can be employed to combat the further spread of DR-MTb strains across the country, especially in rural regions.